Stock Price
2.28
Daily Change
0.08 3.64%
Monthly
18.75%
Yearly
-4.20%
Q3 Forecast
2.34

Peers Price Chg Day Year Date
Avita Medical 1.34 0.01 0.75% -48.46% Sep/05
Aurora Cannabis 6.78 0.09 1.35% -7.50% Sep/05
Acasti Pharma 3.20 0.14 4.58% 32.78% Sep/05
Tectonic Therapeutic 16.80 -0.47 -2.72% -8.50% Sep/05
Cronos Group 3.48 0.03 0.87% 20.42% Sep/05
Knight Therapeutics 6.44 0 0% 14.18% Sep/05
Ionis Pharmaceuticals 61.23 1.88 3.17% 30.58% Sep/05
IQVIA Holdings 187.68 3.60 1.96% -22.83% Sep/05
Dianthus Therapeutics 26.50 1.84 7.46% -0.45% Sep/05
Moderna 25.14 0.86 3.54% -65.54% Sep/05
Organigram Holdings 2.28 0.08 3.64% -4.20% Sep/05
Organon & Co 10.38 0.70 7.23% -49.40% Sep/05
Revvity 86.64 0.94 1.10% -24.90% Sep/05
Tilray 1.64 0.06 3.80% -25.45% Sep/05
Viatris 10.50 0.17 1.65% -6.87% Sep/05
Canopy Growth 2.02 0.11 5.76% -66.72% Sep/05
Xeris Pharmaceuticals 7.85 -0.04 -0.51% 212.75% Sep/05
Alaunos Therapeutics 2.16 0 0% -10.74% Sep/05

Indexes Price Day Year Date
TSX 29051 134.74 0.47% 27.52% Sep/05

Organigram Holdings Inc traded at 2.28 this Friday September 5th, increasing 0.08 or 3.64 percent since the previous trading session. Looking back, over the last four weeks, Organigram Holdings gained 18.75 percent. Over the last 12 months, its price fell by 4.20 percent. Looking ahead, we forecast Organigram Holdings Inc to be priced at 2.34 by the end of this quarter and at 2.29 in one year, according to Trading Economics global macro models projections and analysts expectations.